Copyright Reports & Markets. All rights reserved.

Global Preimplantation Genetic Screening (PGS) Technology Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Preimplantation Genetic Screening (PGS) Technology Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Next-generation Sequencing
    • 1.2.3 Polymerase Chain Reaction
    • 1.2.4 Fluorescence in Situ Hybridization
    • 1.2.5 Comparative Genomic Hybridization
    • 1.2.6 Single-nucleotide Polymorphism
  • 1.3 Market by Application
    • 1.3.1 Global Preimplantation Genetic Screening (PGS) Technology Market Share by Application: 2020 VS 2026
    • 1.3.2 Maternity Centers & Fertility Clinics
    • 1.3.3 Hospitals
    • 1.3.4 Research Laboratories & Academic Institutes
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Preimplantation Genetic Screening (PGS) Technology Market Perspective (2015-2026)
  • 2.2 Global Preimplantation Genetic Screening (PGS) Technology Growth Trends by Regions
    • 2.2.1 Preimplantation Genetic Screening (PGS) Technology Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Preimplantation Genetic Screening (PGS) Technology Historic Market Share by Regions (2015-2020)
    • 2.2.3 Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Preimplantation Genetic Screening (PGS) Technology Players by Market Size
    • 3.1.1 Global Top Preimplantation Genetic Screening (PGS) Technology Players by Revenue (2015-2020)
    • 3.1.2 Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Players (2015-2020)
  • 3.2 Global Preimplantation Genetic Screening (PGS) Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Preimplantation Genetic Screening (PGS) Technology Revenue
  • 3.4 Global Preimplantation Genetic Screening (PGS) Technology Market Concentration Ratio
    • 3.4.1 Global Preimplantation Genetic Screening (PGS) Technology Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Preimplantation Genetic Screening (PGS) Technology Revenue in 2019
  • 3.5 Key Players Preimplantation Genetic Screening (PGS) Technology Area Served
  • 3.6 Key Players Preimplantation Genetic Screening (PGS) Technology Product Solution and Service
  • 3.7 Date of Enter into Preimplantation Genetic Screening (PGS) Technology Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Preimplantation Genetic Screening (PGS) Technology Breakdown Data by Type (2015-2026)

  • 4.1 Global Preimplantation Genetic Screening (PGS) Technology Historic Market Size by Type (2015-2020)
  • 4.2 Global Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Type (2021-2026)

5 Preimplantation Genetic Screening (PGS) Technology Breakdown Data by Application (2015-2026)

  • 5.1 Global Preimplantation Genetic Screening (PGS) Technology Historic Market Size by Application (2015-2020)
  • 5.2 Global Preimplantation Genetic Screening (PGS) Technology Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Preimplantation Genetic Screening (PGS) Technology Market Size (2015-2026)
  • 6.2 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2015-2020)
  • 6.3 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2015-2020)
  • 6.4 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Preimplantation Genetic Screening (PGS) Technology Market Size (2015-2026)
  • 7.2 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2015-2020)
  • 7.3 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2015-2020)
  • 7.4 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Preimplantation Genetic Screening (PGS) Technology Market Size (2015-2026)
  • 8.2 China Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2015-2020)
  • 8.3 China Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2015-2020)
  • 8.4 China Preimplantation Genetic Screening (PGS) Technology Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Preimplantation Genetic Screening (PGS) Technology Market Size (2015-2026)
  • 9.2 Japan Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2015-2020)
  • 9.3 Japan Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2015-2020)
  • 9.4 Japan Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Preimplantation Genetic Screening (PGS) Technology Market Size (2015-2026)
  • 10.2 Southeast Asia Preimplantation Genetic Screening (PGS) Technology Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Preimplantation Genetic Screening (PGS) Technology Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Preimplantation Genetic Screening (PGS) Technology Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 Illumina
    • 11.1.1 Illumina Company Details
    • 11.1.2 Illumina Business Overview
    • 11.1.3 Illumina Preimplantation Genetic Screening (PGS) Technology Introduction
    • 11.1.4 Illumina Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2015-2020))
    • 11.1.5 Illumina Recent Development
  • 11.2 Thermo Fisher Scientific
    • 11.2.1 Thermo Fisher Scientific Company Details
    • 11.2.2 Thermo Fisher Scientific Business Overview
    • 11.2.3 Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Introduction
    • 11.2.4 Thermo Fisher Scientific Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2015-2020)
    • 11.2.5 Thermo Fisher Scientific Recent Development
  • 11.3 Agilent Technologies
    • 11.3.1 Agilent Technologies Company Details
    • 11.3.2 Agilent Technologies Business Overview
    • 11.3.3 Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Introduction
    • 11.3.4 Agilent Technologies Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2015-2020)
    • 11.3.5 Agilent Technologies Recent Development
  • 11.4 PerkinElmer
    • 11.4.1 PerkinElmer Company Details
    • 11.4.2 PerkinElmer Business Overview
    • 11.4.3 PerkinElmer Preimplantation Genetic Screening (PGS) Technology Introduction
    • 11.4.4 PerkinElmer Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2015-2020)
    • 11.4.5 PerkinElmer Recent Development
  • 11.5 Coopersurgical
    • 11.5.1 Coopersurgical Company Details
    • 11.5.2 Coopersurgical Business Overview
    • 11.5.3 Coopersurgical Preimplantation Genetic Screening (PGS) Technology Introduction
    • 11.5.4 Coopersurgical Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2015-2020)
    • 11.5.5 Coopersurgical Recent Development
  • 11.6 Natera
    • 11.6.1 Natera Company Details
    • 11.6.2 Natera Business Overview
    • 11.6.3 Natera Preimplantation Genetic Screening (PGS) Technology Introduction
    • 11.6.4 Natera Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2015-2020)
    • 11.6.5 Natera Recent Development
  • 11.7 Takara Bio
    • 11.7.1 Takara Bio Company Details
    • 11.7.2 Takara Bio Business Overview
    • 11.7.3 Takara Bio Preimplantation Genetic Screening (PGS) Technology Introduction
    • 11.7.4 Takara Bio Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2015-2020)
    • 11.7.5 Takara Bio Recent Development
  • 11.8 Oxford Gene Technology
    • 11.8.1 Oxford Gene Technology Company Details
    • 11.8.2 Oxford Gene Technology Business Overview
    • 11.8.3 Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Introduction
    • 11.8.4 Oxford Gene Technology Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2015-2020)
    • 11.8.5 Oxford Gene Technology Recent Development
  • 11.9 INVICTA
    • 11.9.1 INVICTA Company Details
    • 11.9.2 INVICTA Business Overview
    • 11.9.3 INVICTA Preimplantation Genetic Screening (PGS) Technology Introduction
    • 11.9.4 INVICTA Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2015-2020)
    • 11.9.5 INVICTA Recent Development
  • 11.10 Genea
    • 11.10.1 Genea Company Details
    • 11.10.2 Genea Business Overview
    • 11.10.3 Genea Preimplantation Genetic Screening (PGS) Technology Introduction
    • 11.10.4 Genea Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2015-2020)
    • 11.10.5 Genea Recent Development
  • 11.11 Progenesis
    • 10.11.1 Progenesis Company Details
    • 10.11.2 Progenesis Business Overview
    • 10.11.3 Progenesis Preimplantation Genetic Screening (PGS) Technology Introduction
    • 10.11.4 Progenesis Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2015-2020)
    • 10.11.5 Progenesis Recent Development
  • 11.12 Igenomix
    • 10.12.1 Igenomix Company Details
    • 10.12.2 Igenomix Business Overview
    • 10.12.3 Igenomix Preimplantation Genetic Screening (PGS) Technology Introduction
    • 10.12.4 Igenomix Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2015-2020)
    • 10.12.5 Igenomix Recent Development
  • 11.13 Reproductive Health and Wellness Center
    • 10.13.1 Reproductive Health and Wellness Center Company Details
    • 10.13.2 Reproductive Health and Wellness Center Business Overview
    • 10.13.3 Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Introduction
    • 10.13.4 Reproductive Health and Wellness Center Revenue in Preimplantation Genetic Screening (PGS) Technology Business (2015-2020)
    • 10.13.5 Reproductive Health and Wellness Center Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Preimplantation Genetic Screening (PGS) Technology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Preimplantation Genetic Screening (PGS) Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Next-generation Sequencing
    Polymerase Chain Reaction
    Fluorescence in Situ Hybridization
    Comparative Genomic Hybridization
    Single-nucleotide Polymorphism

    Market segment by Application, split into
    Maternity Centers & Fertility Clinics
    Hospitals
    Research Laboratories & Academic Institutes
    Others

    Based on regional and country-level analysis, the Preimplantation Genetic Screening (PGS) Technology market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Preimplantation Genetic Screening (PGS) Technology market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Illumina
    Thermo Fisher Scientific
    Agilent Technologies
    PerkinElmer
    Coopersurgical
    Natera
    Takara Bio
    Oxford Gene Technology
    INVICTA
    Genea
    Progenesis
    Igenomix
    Buy now